Currently, there are 113.21M common shares owned by the public and among those 106.32M shares have been available to trade.
Insiders at the company have transacted a total of 37 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, accounting for 813,140 shares. Insider sales of the common stock occurred on 29 occasions, with total insider shares sold totaling 148,196 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 1.4450, up 29.81%. The company’s stock has a 5-day price change of 49.17% and 77.33% over the past three months. KPTI shares are trading 56.07% year to date (YTD), with the 12-month market performance down to -61.54% lower. It has a 12-month low price of $0.62 and touched a high of $4.87 over the same period. KPTI has an average intraday trading volume of 1.19 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 62.35%, 66.13%, and -10.86% respectively.
Institutional ownership of Karyopharm Therapeutics Inc (NASDAQ: KPTI) shares accounts for 70.81% of the company’s 113.21M shares outstanding.
It has a market capitalization of $154.62M and a beta (3y monthly) value of -0.10. The earnings-per-share (ttm) stands at -$1.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 21.36% over the week and 13.46% over the month.
Analysts forecast that Karyopharm Therapeutics Inc (KPTI) will achieve an EPS of $OPTEC INTERNATIONAL INC for the current quarter, $0.00 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $M-tron Industries, Inc. while analysts give the company a high EPS estimate of $SPDR Portfolio Intermediate Ter. Comparatively, EPS for the current quarter was $SPTI a year ago. Earnings per share for the fiscal year are expected to increase by 40.56%, and 6.57% over the next financial year.
Looking at the support for the KPTI, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on January 19, 2023, with the firm’s price target at $8.
